Personal Satisfaction: Clinical Trials

20 trials for Personal Satisfaction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed. 20 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 320Completed 20
Phase 23Completed 3

Follow Personal Satisfaction: new trials by email Literature Review of Personal Satisfaction trials Research Report on Personal Satisfaction

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Topical Lidocaine and Benzocaine on Pain Level and Injection Satisfaction
Lidocaine Spray: Each ml contained 10 mg lidocaine and ethanol. Applied to the local site to provide anesthesia, Benzocaine spray, Placebo group (control arm) - Pain, Satisfaction
Phase 3CompletedTC Erciyes University602024-04-012025-12-01
Opioid Analgesic Reduction Study
opioid-containing analgesic, two over-the-counter analgesics - Opioid Use
Phase 3CompletedRutgers, The State University of New Jersey18152021-01-042026-08-31
Homeless Care Management App
In-Person Case Management at Homeless Recovery Program, Unlimited Smartphone, Smartphone Based Case Management (SPCM) app - Substance Use Disorders, Mental Health Impairment
Phase 3CompletedUniversity of Oklahoma4032018-04-272024-12-19
Improvement of Tolerance of Bowel Cleansing Before Colonoscopy in Diabetic Patients
PEG-ascorbate 2L, PEG 4L - Diabetes Mellitus, Colonic Diseases
Phase 3CompletedParc de Salut Mar1582014-12-022017-02-23
Diet for Colonoscopy Preparation in Diabetic Patients
Low-residue diet, Usual care - Diabetes Mellitus, Colonic Diseases
Phase 3CompletedParc de Salut Mar1502014-12-012016-04-12
Effect of Pectoral Electrostimulation on Reduction of Mammary Ptosis
PENS, Specific training - Satisfaction
Phase 3CompletedHospital General Universitario Elche452014-01-012015-05-05
Recruiting to Clinical Trials on the Telephone
telephone, consultation face-to-face - Parental Consent, Newborn
Phase 3CompletedGorm Greisen1252013-07-012015-10-07
VA Augmentation and Switching Treatments for Improving Depression Outcomes
Switching: Bupropion-SR, Augmenting: Antidepressant + Bupropion-SR, Augmenting: Antidepressant + Aripiprazole - Major Depressive Disorder
Phase 3CompletedVA Office of Research and Development15222012-12-012018-05-29
Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy
Oral alprazolam, Sublingual alprazolam, Oral placebo - Diagnostic Esophagogastroduodenoscopy
Phase 2 / Phase 3CompletedIsfahan University of Medical Sciences2202011-09-012013-10-18
Efficacy of System Constellations in a General Population
system constellations seminar - Psychological Well-being
Phase 2 / Phase 3CompletedHeidelberg University2162011-02-012012-02-09
Mindfulness-based Stress Reduction for Pediatric Mental Health
Mindfulness-based stress reduction program, Usual care - Mental Health Wellness 1
Phase 3CompletedUniversity of Alberta852011-01-012013-12-10
The Effect of Thai Traditional Music on Cognitive Function, Psychological Health and Quality of Sleep Among Thai Older Individuals With Dementia
Music CD - Cognitive Function, Sleep
Phase 3CompletedPhramongkutklao College of Medicine and Hospital602010-02-012011-01-05
Efficacy of Morning-only Bowel Preparation for Afternoon Colonoscopy.
Polyethylene Glycol afternoon, Polyethylene Glycol morning - Colon Cancer
Phase 3CompletedCleveland Clinic Florida1362008-02-012017-05-17
Denosumab Adherence Preference Satisfaction Study
alendronate, denosumab - Osteoporosis
Phase 3CompletedAmgen2502007-09-012019-12-03
Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
sumatriptan succinate/naproxen sodium, placebo - Migraine Disorders, Migraine
Phase 3CompletedGlaxoSmithKline6462005-10-012015-04-16
Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
sumatriptan succinate/naproxen sodium, placebo - Migraine Disorders
Phase 3CompletedGlaxoSmithKline6232005-10-012016-10-26
Effect of the 'Mother and Baby' Program on Well-Being
Exercise and education, Education - Postnatal Depression
Phase 3CompletedUniversity of Melbourne1602005-07-012008-08-13
Improving Primary Care in Patients With Mental Disorders
Nurse case management, Usual care - Mental Disorders
Phase 3CompletedEmory University4072004-07-012013-11-19
St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)
Hypericum perforatum (St. John's wort) - Anxiety Disorders, Mental Health
Phase 2 / Phase 3CompletedNational Center for Complementary and Integrative Health (NCCIH)562002-08-012007-09-26
CAFE Comparison of Atypicals in First Episode of Psychosis
Olanzapine, risperidone - Schizophrenia, Psychotic Disorders
Phase 3CompletedAstraZeneca2002-03-012013-01-04

Narrower conditions

Psychological Well-Being (9)  ·  Mental Disorders (3)  ·  Anxiety Disorders (2)  ·  Colonic Diseases (2)  ·  Diabetes Mellitus (2)  ·  Migraine Disorders (2)  ·  Pain (2)  ·  Patient Compliance (2)  ·  Agnosia (1)  ·  Arteriovenous Fistula (1)  ·  Bone Diseases, Metabolic (1)  ·  Colonic Neoplasms (1)  ·  Dementia (1)  ·  Depression (1)

Broader conditions

Behavior (20)  ·  Mental Disorders (6)  ·  Nervous System Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Digestive System Diseases (3)  ·  Gastrointestinal Diseases (3)  ·  Intestinal Diseases (3)  ·  Metabolic Diseases (3)  ·  Neurologic Manifestations (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Signs and Symptoms (3)  ·  Chemically-Induced Disorders (2)

Interventions

Naproxen (2)  ·  Sumatriptan (2)  ·  Alendronate (1)  ·  Alprazolam (1)  ·  Amyloid (1)  ·  Aripiprazole (1)  ·  Denosumab (1)  ·  Educational Status (1)  ·  Exercise (1)  ·  Golytely (1)  ·  Hypericum extract LI 160 (1)  ·  Lidocaine (1)  ·  MoviPrep (1)  ·  Olanzapine (1)  ·  Risperidone (1)

Sponsors

GlaxoSmithKline (2)  ·  Parc de Salut Mar (2)  ·  Amgen (1)  ·  AstraZeneca (1)  ·  Cleveland Clinic Florida (1)  ·  Emory University (1)  ·  Gorm Greisen (1)  ·  Heidelberg University (1)  ·  Hospital General Universitario Elche (1)  ·  Isfahan University of Medical Sciences (1)  ·  National Center for Complementary and Integrative Health (NCCIH) (1)  ·  Phramongkutklao College of Medicine and Hospital (1)  ·  Rutgers, The State University of New Jersey (1)  ·  TC Erciyes University (1)  ·  University of Alberta (1)

Countries

United States (9)  ·  Canada (2)  ·  Spain (2)  ·  Australia (1)  ·  Germany (1)  ·  Iran (1)  ·  Thailand (1)  ·  Turkey (Türkiye) (1)

Top investigators

Ahmad Shavakhi, M.D. (1)  ·  Akarachaid Pinidbunjerdkool, MD (1)  ·  Benjamin G. Druss, MD, MPH (1)  ·  Cecile A Feldman, DMD (1)  ·  Chananya Potisuk (1)  ·  Emily Ashby, BPhysio (1)  ·  Jaime Ruiz-Tovar, MD, PhD (1)  ·  Jennifer M Reingle, Ph.D. (1)  ·  Jochen Schweitzer-Rothers, Professor (1)  ·  Kanokporn Wonganankit (1)  ·  Kim Foss, MD (1)  ·  Margaret Sherburn, MWHlth (1)

Results publications

PMID 20855373, PMID 17606657, PMID 17606658, PMID 18312044, PMID 20008945, PMID 20056720, PMID 20606677, PMID 24251855, PMID 24977401, PMID 27479536, PMID 27490086, PMID 27871308, PMID 28697253, PMID 29871852, PMID 30695291, PMID 30947531, PMID 31665314, PMID 32603560, PMID 32677243, PMID 33225492, PMID 35177108, PMID 35366613, PMID 37859623, PMID 39755971, PMID 40742171

NIH funding

5UH3DE028860-05 (1), R01MD010733 (1), R01MH070437 (1)